Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis

Alemtuzumab exerts its clinical efficacy by its specific pattern of depletion and repopulation of different immune cell subsets. Recently, single cases of multiple sclerosis patients who developed severe exacerbation after the first alemtuzumab application, accompanied by re-appearance of peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Akgün, Katja, Metz, Imke, Kitzler, Hagen H., Brück, Wolfgang, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846919/
https://www.ncbi.nlm.nih.gov/pubmed/29552092
http://dx.doi.org/10.1177/1756286418759895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846919/
https://www.ncbi.nlm.nih.gov/pubmed/29552092
http://dx.doi.org/10.1177/1756286418759895

Ejemplares similares